Cancer Drug Category Facing 34% to 42% Growth
More like this
- Specialty Pharmacy Management Will Become More Intense
- Do the Numbers Add Up for Oral Oncology Quantity-Limit Programs?
- Plans Confront Specialty Pharmacy’s Escalating Costs in Variety of Ways
- Benefit and Formulary Options Appear in Specialty Pharmacy
- Employers Need to Better Understand the Costs of Specialty Pharmacy